Elekta Files Patent Infringement Lawsuit Against ZAP Surgical Systems Inc.
SUNNYVALE, California, April 26, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST), a pioneer in development of precision radiation therapy, radiosurgery and clinical software for the treatment of cancer and neurological disorders, announced today it has filed a patent infringement lawsuit against ZAP Surg...
Elekta Hits Radiotherapy Milestone With 5,000th Linear Accelerator Manufactured
STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades[1-2], access to radiotherapy - a key treatment modality for up to 60 percent of cancer patients - is more critical than ever. Since the manufacture ...
St. Vincent's Health Australia Expanding MOSAIQ Medical Oncology EHR to Total of Six Departments
SYDNEY, April 24, 2018 /PRNewswire/ -- St. Vincent's Health Australia (SVHA)
will expand its use of Elekta'sMOSAIQ® Medical Oncology
Genesis CancerCare Queensland is First in Asia-Pacific Region to use Elekta's Venezia Brachytherapy Applicator
BRISBANE, Australia, Sept. 11, 2017 /PRNewswire/ -- On June 13, clinicians at Genesis CancerCare Queensland delivered the first of three high dose rate brachytherapy treatments to a woman with loco-regionally advanced stage (IIB) cervical cancer. The patient's post-chemoradiation brachytherapy bo...
Elekta Introduces Advanced Cancer Treatment to Kingdom of Bhutan
THIMPHU, Bhutan, July 24, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has been chosen to deliver the first ever radiation therapy system to the Kingdom ofBhutan. The National Referral Hospital, the largest hospital in the Kingdom, will install an Elekta Compact™ linear acceler...
Elekta Flexitron brachytherapy treatment delivery available in China
BEIJING, Dec. 18, 2014 /PRNewswire/ -- Elekta (EKTA-B.ST) announces that the
China Food and Drug Administration (CFDA) has approved Elekta'sFlexitron®
